Parents on GLP-1s Face New Parenting Challenge: How to Talk Kids Through Weight Loss Drugs

Millions of American parents have begun taking GLP-1 drugs—medications originally developed for diabetes that suppress appetite and promote weight loss. As these prescriptions have proliferated in households across the country, a quieter question has emerged: what do you tell your children when they notice the injections in the refrigerator, the weekly ritual, the visible changes in your body? The question has become urgent enough that pediatricians, psychologists, and parents themselves are now grappling with how to frame these medications in ways that don't inadvertently teach children to fear their own bodies or to see weight as a moral failing.

The scale of adult adoption is substantial. Millions of parents are now using these drugs, which work by mimicking a hormone that regulates blood sugar and appetite. For many, the decision to start treatment was personal—a response to years of unsuccessful dieting, health concerns, or simply the desire to feel better in their bodies. But the visibility of that choice within a family unit creates new terrain. A child sees a parent injecting themselves weekly. A teenager notices the weight loss. Siblings compare notes. The medication becomes a household fact, and children naturally begin to construct narratives around it.

Meanwhile, the pharmaceutical industry is moving downstream. Companies are now testing GLP-1 drugs in children as young as six years old, though pediatric prescriptions remain uncommon relative to adult use. The prescriptions that do exist for young children are rising, according to data tracked by consumer health organizations, but they still represent a small fraction of overall GLP-1 use. This gap between what is happening in adult medicine and what may happen in pediatric care has created a moment of uncertainty. Parents are living with these drugs now; their children may be prescribed them later. The question of how to talk about them—and what messages those conversations send—sits in that space between present reality and approaching future.

Experts in child psychology and pediatric medicine have begun offering guidance, though consensus remains incomplete. The core tension is straightforward: how do you normalize a medical treatment without normalizing the idea that a child's body is a problem to be solved? How do you explain that a parent's weight loss is a health decision without implying that weight itself is a character issue? Teenagers, in particular, report feeling pressure when they see weight loss drugs in their households. Some worry they will be expected to use them. Others internalize the message that their own bodies are inadequate. The psychological weight of the medication can exceed the physical weight it removes.

The conversation is further complicated by the fact that these drugs work. Parents taking them often experience significant weight loss and improved metabolic markers. The results are real, and for many, the health benefits are genuine. But results alone do not resolve the communication challenge. A parent's successful treatment can become a child's source of anxiety, particularly if that child has inherited genetic predispositions toward weight gain or if they are already struggling with body image. The medication becomes a mirror in which children see their own future—a future in which their bodies might also require pharmaceutical intervention.

Some families are approaching the conversation with deliberate honesty. They explain that the medication is a tool, like glasses or insulin, and that using it reflects a choice about health, not a judgment about worth. Others are finding that the conversation is harder than expected—that children absorb messages from culture, from peers, from social media, and that a parent's careful framing can only do so much. Still others are choosing not to discuss it at all, hoping that silence will prevent the medication from becoming a focal point in their children's thinking about bodies and health.

What remains unclear is how these household conversations will shape the next generation's relationship with weight, medicine, and their own bodies. The drugs are here. The prescriptions are rising. And parents are navigating a landscape that has no clear map, trying to model health without modeling shame, trying to normalize treatment without normalizing the idea that treatment is necessary for acceptability. The answer to how to talk to your kids about GLP-1s may ultimately depend less on what experts recommend and more on what each family decides its values actually are.